NCT06826235Recruiting
Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 Diabetes
Tip 2 Diyabetli Yetişkin Bireylerde Hurma Tüketiminin Hedonik Açlık ve İştah Hormonları Üzerine Etkilerinin İncelenmesi
Source: ClinicalTrials.gov · Last updated 13 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study was to investigate the effects of date consumption on hedonic hunger and appetite hormones in individuals diagnosed with type 2 diabetes.The main questions it aims to answer are: * Does date consumption reduce hedonic hunger in individuals with type 2 diabetes? * Does persimmon consumption change Ghrelin, GLP-1 and GIP concentrations in individuals with Type 2 diabetes? * Does persimmon consumption reduce HOMA-IR and HbA1c values in individuals with Type 2 diabetes? * Does consumption of persimmon reduce LDL cholesterol, total cholesterol and triglyceride concentrations in individuals with type 2 diabetes? To see the effects of date consumption on hedonic hunger and appetite hormones, the researchers will compare individuals with type 2 diabetes who consume 3 dates daily with individuals with type 2 diabetes who do not. Participants: * Individuals in the intervention group will consume 3 (25 g) Baghdad dates (15 g CHO) daily as part of the breakfast meal, while individuals in the control group will not consume dates. * Three interviews will be conducted with patients. * A record of blood findings and questionnaires will be kept during these interviews.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- First submitted
- 23 Jan 2025
- Start date
- 14 May 2024
- Primary completion date
- 1 Mar 2025
- Lead sponsor
- Hacettepe University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06826235
What you commit to
- Study type: Interventional
- Planned participants: 64
- From 14 May 2024 to the primary completion date, 1 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals with a history of diabetic ketoacidosis, diabetic coma or precoma within 6 months prior to the date of admission; serious infections, surgery, serious trauma requiring insulin treatment, haemodialysis treatment (including peritoneal haemodialysis), serious liver injury and serious vascular complications (stroke, myocardial infarction and heart failure) requiring hospitalisation,
- Individuals taking pharmacological agents that have effects on appetite such as psychotropics, antiepileptics, antidepressants, antipsychotics and/or steroids,
Other illness
- Individuals with pre-diabetes, type 1 diabetes and gestational diabetes,
- Individuals taking antibiotics or hormone replacement therapy History of malignancy (except non-melanoma skin cancer).
- Individuals diagnosed with Type 2 diabetes using insulin and oral antidiabetic drugs with thiazolidinedione active substance,
- Individuals diagnosed with eating disorders and/or psychological disorders,
- Individuals with physical illnesses that affect eating behaviour or appetite, such as uncontrolled hyperthyroidism or hypothyroidism, Cushing's disease, acromegaly, adrenal insufficiency, chronic renal failure (stage 4 or 5), tuberculosis, human immunodeficiency virus (HIV) infection.
Lab values
- Individuals with HbA1c \>10
Other
- Individuals who do not approve the volunteer consent form,
- Individuals with a Nutritional Strength Scale score below 2.5,
- Pregnant or breastfeeding women (or women planning to become pregnant within 3 months)
- Individuals with dietary energy \<800 kcal/day and \>4000 kcal/day,
- Individuals with regular consumption of dates before inclusion in the study,
Who the study is looking for
- Individuals diagnosed with Type 2 diabetes aged 19-50 years (excluding menopausal women),
- Individuals with BMI between 25-35 kg/m2,
- Individuals with a Nutritional Strength Scale score of 2.5 and above,
- Individuals who agreed not to start taking new dietary supplements or alternative therapies during the study period,
- Individuals who agree not to change their current physical activity level and diet.
Age in the registry: 19 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erzurum City Hospital Coordinator of this site? Confirm its status | Erzurum | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.